Main Directory
Articles 2591
CME 2
eCommerce 0
Medical Web Sites Directory 93
Podcasts 94
Web Design and Hosting 2




MEND-CABG II: No Benefit of MC-1 in Reducing Death/MI Post-CABG
Link ID 4587
Title MEND-CABG II: No Benefit of MC-1 in Reducing Death/MI Post-CABG
Url http://www.medscape.com/viewarticle/572575?src=rss
Description The lead investigator says the drug, based on a metabolite of vitamin B6, likely has no future as a cardioprotective agent in bypass surgery but may yet prove to have other beneficial metabolic properties, provided its developer has deep enough pockets to continue to study it. Heartwire
Category Articles > Cardiology
Keywords
Date Apr 5, 2008
Contact Name
Email
Write a Review   Add to My Favorite   Refer it to Friend   Report Broken Link  

Average Visitor Rating: 0.00 (out of 5)
Number of ratings: 0 Votes
Visitor Rating

 Other links at Articles > Cardiology
1. Pacemaker Syndrome - a Forgotten Diagnosis?
  The diagnosis of pacemaker syndrome requires a high index of suspicion and the correlation of symptoms or relative hypotension with periods of ventricular pacing.
British Journal of Cardiology
Category:   Articles > Cardiology


2. Using Clinical Guidelines to Aggressively Manage Dyslipidemia
  Improve patient care by recognizing the signs of dyslipidemia earlier and exploring ways to aggressively overcome treatment barriers.
Category:   Articles > Cardiology


3. "Precipitating Factors" Influence Heart Failure Outcomes
  More attention to factors that contribute to hospitalizations for heart failure, such as pneumonia or uncontrolled hypertension, could improve overall management of this condition, a new study shows. Medscape Medical News
Category:   Articles > Cardiology


4. How Do the Next Generation of Drug-Eluting Stents Compare With the Taxus Stent?
  TCT 2007: From zotarolimus to everolimus and from EPC-capturing stents to titanium-nitric-oxide-coated stents -- will the new-generation stents outmatch the paclitaxel-eluting stent?
Medscape Cardiology
Category:   Articles > Cardiology


5. VICTORY: "Reassuring" Atherosclerosis/Metabolic Data on Rosiglitazone
  The drug showed a trend toward a slowing of the progression of atherosclerosis and an overall positive effect on metabolic factors in the VICTORY study in post-CABG diabetes patients. Heartwire
Category:   Articles > Cardiology




Home      New Listings      Hot Listings      Top Rated      Editor Pick      Add a Listing      Update a Listing      Get Rated      Upgrade a Listing
Valid XHTML 1.0 Transitional   Valid CSS